Ardelyx Inc
NASDAQ:ARDX
Ardelyx Inc
NASDAQ:ARDX
Price:
8.72 USD
28.42%
Market Closed
Updated:
May 5, 2024
Ardelyx Inc
Revenue
|
Ardelyx Inc
Revenue Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ardelyx Inc
NASDAQ:ARDX
|
Revenue
$124.5m
|
CAGR 3-Years
154%
|
CAGR 5-Years
117%
|
CAGR 10-Years
16%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Ardelyx Inc
Revenue Breakdown
Breakdown by Geography
Ardelyx Inc
Ardelyx Inc
|
Total Revenue:
124.5m
USD
|
|
United States:
83.3m
USD
|
|
Asia Pacific:
41.1m
USD
|
|
North America:
59k
USD
|
Breakdown by Segments
Ardelyx Inc
Ardelyx Inc
Not Available
See Also
What is Ardelyx Inc's Revenue?
Revenue
124.5m
USD
124.5m
USD
Based on the financial report for Dec 31, 2023, Ardelyx Inc's Revenue amounts to 124.5m USD.
What is Ardelyx Inc's Revenue growth rate?
Revenue CAGR 10Y
16%
16%
Over the last year, the Revenue growth was 139%. The average annual Revenue growth rates for Ardelyx Inc have been 154% over the past three years , 117% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
